Joydeep Ganguly evaluates 4IR tools, data strategy, and why end-to-end thinking will define pharma supply chain ...

The biotech industry has pushed the boundaries of human health and scientific understanding for decades. But a new revolution is brewing—not in the lab, but in the supply chain. By embracing ...

Chinese biotech firms are striking big global deals as drug makers, but could artificial intelligence take them to the next ...

As drug candidates advance closer to commercialization, scientific progress is no longer viewed solely as research expenditure but increasingly as a measurable financial asset. This shift is being ...

As therapeutic candidates advance toward commercialization, scientific achievement is no longer viewed purely as an expense tied to research and development but rather as something that can be ...

Global CPHI events underscore international sourcing and partnership dynamics, with Shanghai’s CPHI & PMEC China illustrating ...

PISCATAWAY, N.J., Jan. 7, 2025 /PRNewswire/ -- GenScript Biotech Corporation, a global leader in life sciences research and manufacturing services, has officially joined the Pharmaceutical Supply ...

Global uncertainties over the past two years, including US President Donald Trump’s tariff threats, price erosion in the ...

DUBLIN--(BUSINESS WIRE)--The "AI in Biotechnology: Global Markets" report has been added to ResearchAndMarkets.com's offering. The global market for AI in biotechnology was valued at $3.8 billion in ...

Investors' deep pessimism is actually bullish, and less regulatory constraint could fuel new drug approval and M&A Biotech is one of the U.S. stock market's most unloved sectors. But several ...